South Korean drugmaker Daewoong Pharma said on Thursday it had sought regulatory approval for Phase II trials of its antiparasite niclosamide drug to treat COVID19 patients, sending its shares up nearly 6%.
from Top Business News- News18.com
Read The Rest:timesnownews...
from Top Business News- News18.com
Read The Rest:timesnownews...
South Korea Daewoong Pharma Eyes Phase II Trials Of Coronavirus Drug, Shares Jump
Reviewed by Team Exprssnews
on
December 03, 2020
Rating:
No comments: